Development of Agranulocytosis after Discontinuation of Methimazole: An Unusual Case
Agranulocytosis is a rare and critical adverse effect of antithyroid drugs (ATD). The occurrence of agranulocytosis in continuous ATD treatment patients is well known; however, a case of ATD agranulocytosis occurring following the discontinuation of methimazole (MMI) treatment is not a usual situati...
Saved in:
Main Authors: | Rıfkı Üçler, Murat Atmaca, Ömer Candar, Murat Alay, Burhan Göy, Erdal Kara, Mahfuz Turan, Yusuf Demir |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2015/974524 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil
by: Jaeduk Yoshimura Noh, et al.
Published: (2024-07-01) -
Glycogenic Hepatopathy in Type 1 Diabetes Mellitus
by: Murat Atmaca, et al.
Published: (2015-01-01) -
Methimazole-Induced Cholestatic Jaundice: A Rare Case and Literature Review
by: Ahmed Mohamed Nefzi, et al.
Published: (2025-02-01) -
Agranulocytosis Associated with Topiramate: A Case Report and Review of Published Cases
by: Saroj Lohani, et al.
Published: (2018-01-01) -
Methimazole Inhibits the Expression of GFAP and the Migration of Astrocyte in Scratched Wound Model In Vitro
by: Lina Zhao, et al.
Published: (2020-01-01)